Company Filing History:
Years Active: 1990-1993
Title: Eduard Porges: Innovator in Pharmaceutical Formulations
Introduction
Eduard Porges, a notable inventor located in Cologne, Germany, has made significant contributions to the field of pharmaceutical formulations. As an innovator, he holds two patents that reflect his expertise and dedication in developing effective medical solutions.
Latest Patents
Porges' latest patents include a "Solid composition containing dihydropyridine, PVP and PVPP," which describes a solid, rapidly absorbable composition. This composition consists of 1 part by weight of nimodipine, 0.01 to 1.5 parts of polyvinylpyrrolidone with an average molecular weight of 15,000 to 50,000, and 1 to 12 parts by weight of crosslinked insoluble polyvinylpyrrolidone. Additionally, he has developed a "Dihydropyridine depot formulation," which is a pharmaceutical tablet designed for long-lasting action, suitable for 1 to 2 daily doses, featuring a diameter between about 0.5 and 15 mm.
Career Highlights
Currently, Eduard Porges is affiliated with Bayer Aktiengesellschaft, a renowned company in the pharmaceutical field. His work at Bayer emphasizes his commitment to advancing medical treatments through innovative product development.
Collaborations
Throughout his career, Porges has collaborated with other esteemed professionals in the industry, such as Helmut Luchtenberg and Andreas Ohm. These collaborations have further enriched his research and invention process, leading to impactful pharmaceutical advancements.
Conclusion
Eduard Porges stands out as a skilled inventor whose work within Bayer Aktiengesellschaft continues to enhance pharmaceutical formulations. With his innovative patents, he plays a vital role in improving health outcomes through effective medical solutions. His dedication to advancing the field of pharmacology through his inventions exemplifies the importance of innovation in healthcare.